Nature Reviews Rheumatology Issues Research Articles in May 2024 Edition
May 27, 2024
May 27, 2024
NEW YORK, May 27 -- Nature Reviews Rheumatology, a peer-reviewed journal that says it covers the spectrum of rheumatology research, published research articles on the following topics in its May 2024 edition (Vol. 20, Issue 5):
Research Highlights:
* Nanoparticle-based pazopanib shows promise in OA
* Benralizumab noninferior to mepolizumab for EGPA
News & Views:
* All fibroblasts are equal, but some are more equal than others . . .
Research Highlights:
* Nanoparticle-based pazopanib shows promise in OA
* Benralizumab noninferior to mepolizumab for EGPA
News & Views:
* All fibroblasts are equal, but some are more equal than others . . .